pharmaceuticals

• 

  6/4/2025

  Alnylam Pharmaceuticals, Inc. v. Moderna, Inc.: Express Definitions in Patent Specs Can Limit Claim Scope

• 

  5/12/2025

  Incyte Corp. v. Sun Pharmaceutical Industries: Federal Circuit Reverses Preliminary Injunction for Lack of Irreparable Harm

• 

  5/11/2025

  Jazz Pharmaceuticals v. Avadel CNS Pharmaceuticals: Clarifying the Limits of Injunctive Relief Under the Hatch-Waxman Safe Harbor

• 

  3/18/2025

  Regeneron v. Amgen: Patent Infringement and Biologic Formulations

• 3/10/2025

  Patent Law and Drug Innovation: Federal Circuit Upholds Rejection of ImmunoGen’s Patent Application

• 12/10/2024

  Galderma v. Lupin: CAFC Weighs In on ANDA Infringement and the Doctrine of Equivalents

• 9/21/2024

  Federal Circuit Vacates District Court’s Surprise Patent Ineligibility Ruling in Astellas v. Sandoz